Pathologic Fractures of the Proximal Femur Secondary to Benign Bone Tumors

2001 ◽  
Vol 393 ◽  
pp. 279-286 ◽  
Author(s):  
Eugene K. Wai ◽  
Aileen M. Davis ◽  
Anthony Griffin ◽  
Robert S. Bell ◽  
Jay S. Wunder
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Benign Bone Tumors ◽  
Pathologic Fractures

Benign Hand Tumors (Part I): Cartilaginous and Bone Tumors

Hand ◽  
2020 ◽  
pp. 155894472092292
Author(s):  
Kai-Lou C. Yue ◽  
Jonathan Lans ◽  
René M. Castelein ◽  
David I. Suster ◽  
G. Petur Nielsen ◽  
...  
Keyword(s):  
Bone Tumors ◽  
International Classification Of Diseases ◽  
Benign Tumors ◽  
Recurrence Rates ◽  
Giant Cell Tumors ◽  
Intralesional Curettage ◽  
Bony Tissue ◽  
Benign Bone Tumors ◽  
Pathologic Fractures ◽  
Tumors Of The Hand

Background: Benign tumors of the hand present in a wide array of histological subtypes and compose most of the bony tissue tumors in the hand. This study evaluates the characteristics and treatment of benign bone tumors in light of one institution’s experience. Methods: Histologically confirmed benign tumors of the hand were retrospectively identified using International Classification of Diseases codes from 1992 to 2015. A medical chart review was conducted to collect patient characteristics and tumor epidemiology and treatment. Results: A total of 155 benign bone tumors were identified. The median age of patients at the time of surgery was 39.9 ± 12.8 years. All bone tumors were located in the digits, and most were treated by intralesional curettage (n = 118, 76%). Pathologic fractures occurred in 79 bone tumors (51%). Conclusion: Enchondromas (n = 118, 76%) were the most common bone tumor in this series, whereas giant cell tumors were the most destructive and also had the highest recurrence rate (40%). Awareness of tumor features may help physicians with diagnosis, and awareness of recurrence rates is important when counseling patients.

Salvage of the proximal femur following pathological fractures involving benign bone tumors

2015 ◽  
Vol 112 (8) ◽  
pp. 846-852 ◽  
Author(s):  
Pedro I. Carvallo ◽  
Anthony M. Griffin ◽  
Peter C. Ferguson ◽  
Jay S. Wunder
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Pathological Fractures ◽  
Benign Bone Tumors

Salvage of the proximal femur following pathological fractures involving benign bone tumors

2016 ◽  
Vol 114 (2) ◽  
pp. 254-254
Author(s):  
Abhijeet Ashok Salunke ◽  
Jaymin Shah ◽  
Vikas Warikoo ◽  
Ramesh Kumar ◽  
Ashok Galande ◽  
...  
Keyword(s):  
Proximal Femur ◽  
Bone Tumors ◽  
Pathological Fractures ◽  
Benign Bone Tumors

scholarly journals Chondromas and multiple enchondromatosis

2021 ◽  
Vol 27 (4) ◽  
pp. 441-445
Author(s):  
P. Lascombes ◽  
◽  
L. Mainard-Simard ◽  
◽  
Keyword(s):  
Surgical Treatment ◽  
Bone Tumors ◽  
Benign Tumor ◽  
Clinical Presentation ◽  
Radiological Findings ◽  
Benign Bone Tumors ◽  
Multiple Enchondromatosis ◽  
Pathologic Fractures ◽  
Bone Deformities

Introduction The chondromas are a cartilaginous proliferation of mature appearance and moderate size, reason why these tumors are regarded more like hamartomas than real benign tumor. Chondromas represent 10 to 12 % of benign bone tumors. Any bone of an enchondral ossification may be involved. Several bones can be involved, and the disease is called “chondromatosis”. In the review we describe clinical and radiological findings of this pathology as well as indications for reconstructive surgery. Material and methods The review is dedicated to isolated chondromas, periosteal and extraskeletal chondromas, chondromatosis. Results The aspects of epidemiology, clinical presentation, radiology, MRI, prognosis, indications and methods of surgical treatment have been described in the article for each types of chondroma and enchondromatosis. Conclusion Chondromas are benign bone tumors which may be responsible of pathologic fractures. Their surgical treatment consists in curettage and bone grafting or bone-cement filling with or without osteosynthesis. Multiple enchondromatosis should be considered as an osteochondrodysplasia. Its treatment is not the treatment of the multiple chondromas themselves, but of the bone deformities and length discrepancy induced by the disorder. The transformation of some tumors in chondrosarcomas in adolescence or adulthood needs a strict follow up of these patients.

MALIGNANT AND BENIGN BONE TUMORS

2001 ◽  
Vol 39 (4) ◽  
pp. 673-699 ◽  
Author(s):  
Shannon L. Miller ◽  
Fredric A. Hoffer
Keyword(s):  
Bone Tumors ◽  
Benign Bone Tumors

scholarly journals Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions

Open Medicine ◽  
2018 ◽  
Vol 13 (1) ◽  
pp. 487-492 ◽  
Author(s):  
Daniel Kotrych ◽  
Szymon Korecki ◽  
Paweł Ziętek ◽  
Bartosz Kruk ◽  
Agnieszka Kruk ◽  
...  
Keyword(s):  
Bone Substitute ◽  
Bone Tumors ◽  
Bone Cyst ◽  
Bone Diseases ◽  
Long Term Results ◽  
Reconstructive Procedures ◽  
Benign Bone Tumors ◽  
Significant Clinical Improvement ◽  
Tumor Like Lesions

AbstractBackground: CERAMENT™|BONE VOID FILLER is an injectable and moldable ceramic bone substitute material intended for bone voids. The material consists of hydroxyapatite and calcium sulfate hemihydrate. The aim of this study is to present the first long-term results following open curettage of benign bone tumors and tumor-like lesions and void filling with this novel injectable and synthetic bone graft. Methods: Thirty three patients were enrolled into the study between June 2013 and October 2014 .Totally, we treated 24 women and 9 men with a median age of 47 years (range: 22-74). All patients suffered from primary musculoskeletal system disorders (enchondroma 63,6%, giant cell tumor 18%, aneurysmal bone cyst 9%, fibrous dysplasia 9%, Gaucher disease 3%). We performed curettage of pathological lesions, then the bone substitute was administered by means of needle to the void. Results: The average follow-up was 13 months (range: 2-13 months, median 10 months). No metastasis or recurrence had been detected. We received significant clinical improvement relating to VAS, MSTS, and oncological results. Conclusions: The results of our study report that CERAMENT can be successfully used as a bone substitute in patients with various bone diseases, as well as benign bone tumors. CERAMENT can provide an effective and long-term solution for reconstructive procedures following curettage of bone tumors and tumor like lesions.

Benign Bone Tumors

2010 ◽  
pp. 48-49
Author(s):  
Javad Parvizi ◽  
Gregory K. Kim
Keyword(s):  
Bone Tumors ◽  
Benign Bone Tumors
Sign in / Sign up

Export Citation Format

Share Document